marginally significantp ~0.06
Of these BUD patients, benzodiazepine type and duration of use were marginally significant ( p ~0.06), suggesting that BUD were associated more with oxazepam use and with longer benzodiazepine use.
Of these BUD patients, benzodiazepine type and duration of use were marginally significant ( p ~0.06), suggesting that BUD were associated more with oxazepam use and with longer benzodiazepine use.
The only categorical variables of marginal significance ( p ~0.06) in comparison to a BUD diagnosis were with benzodiazepine type (oxazepam) and longer duration of use (greater than 24 months).
17 Whilst this study showed a duration of > 24 months of use being just marginally significant, this finding correlates with findings of studies indicating a link between prolonged use and physical or psychological dependence. 17 Whilst oxazepam has been considered an agent of low abuse potential, 18 it does have a shorter half-life compared to clonazepam that poses as a high-potency benzodiazepine with a long half-life contributing to a ‘safer’ profile. 19 This may account for the marginally significant difference found between the two agents in this study.